What is NDC 0409-4520?

0409-4520 is the product NDC for Heparin Sodium and Dextrose (heparin sodium), Heparin sodium 10000 [USP'U]/100mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Heparin Sodium and Dextrose (Heparin sodium).

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Heparin Sodium and Dextrose?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Heparin Sodium and Dextrose NDC 0409-4520

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-4520Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-4520Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-4520-30	0040945203000409452030	30 POUCH in 1 CASE (0409-4520-30) / 1 BAG in 1 POUCH / 250 mL in 1 BAG (0409-4520-02)Marketed from Dec 12, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Heparin Sodium and Dextrose
Generic name (nonproprietary): heparin sodium
Active ingredients: Heparin sodium — 10000 [USP'U]/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019339
Marketing start: Dec 12, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Heparin (Chemical structure)
Identifiers: Product ID 0409-4520_b2a0ec6b-eee0-46b9-9e8a-ae2442e30771SPL ID b2a0ec6b-eee0-46b9-9e8a-ae2442e30771SPL set ID eede8a0c-5ae6-4166-84b3-12081405f08eRxCUI 1658717UNII ZZ45AB24CA
Pharmacologic class: Anti-coagulant; Unfractionated Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409452030 followed by a unit qualifier and the quantity

Package 00409-4520-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 25, 2026.

Indications (excerpt from the label)

Heparin Sodium in 5% Dextrose Injection is indicated for: • Prophylaxis and treatment of venous thrombosis and pulmonary embolism • Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation • Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation) • Prevention of clotting in arterial and cardiac surgery • Prophylaxis and treatment of peripheral arterial embolism • Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. Heparin Sodium in 5% Dextrose Injection is indicated for: ( 1 ) • Prophylaxis and treatment of venous thrombosis and pulmonary embolism. • Prophylaxis and treat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-4520

What is NDC 0409-4520?: 0409-4520 is the product NDC for Heparin Sodium and Dextrose (heparin sodium), Heparin sodium 10000 [USP'U]/100mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Heparin Sodium and Dextrose (Heparin sodium).
What is the active ingredient?: Heparin sodium.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Heparin Sodium and Dextrose?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Heparin Sodium and Dextrose (Heparin sodium) NDC 0409-4520